SS
TBPH icon

Simplicity Solutions’s Theravance Biopharma TBPH Stock Holding History

Simplicity Solutions’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$141K Buy
+12,584
New +$127K ﹤0.01% 992
2023
Q3 		– Sell
-23,688
Closed -$245K – 1087
2023
Q2 		$245K Buy
+23,688
New +$262K 0.01% 899

Other funds holding TBPH

WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return

Simplicity Solutions's TBPH Position: Q4 2023 in Review

Simplicity Solutions opened a new position in Theravance Biopharma (TBPH) in Q4 2023: 12,584 shares worth $141K. The stake represents ﹤0.01% of the portfolio and ranks #992 among its holdings. This is a return to the name: Simplicity Solutions previously reported a position in TBPH as recently as Q2 2023.

Simplicity Solutions first reported a position in TBPH in Q2 2023 and has held it in 2 quarters since. The position peaked at $245K in Q2 2023. 118 funds tracked by Wall St. Rank hold TBPH as of Q4 2023.

  • Simplicity Solutions held 12,584 shares of Theravance Biopharma worth $141K as of Q4 2023.
  • Theravance Biopharma was a new Simplicity Solutions position in Q4 2023.
  • Theravance Biopharma made up ﹤0.01% of Simplicity Solutions's portfolio in Q4 2023, its #992 holding.
  • Simplicity Solutions first reported a position in Theravance Biopharma in Q2 2023 and has held it in 2 quarters since.
  • Simplicity Solutions's Theravance Biopharma position peaked at $245K in Q2 2023.
  • 118 funds tracked by Wall St. Rank held Theravance Biopharma as of Q4 2023.

Based on Simplicity Solutions's 13F filing for Q4 2023, filed 29 Jan 2024.